TITLE

Toll-like receptor 2 is critical for induction of Reg3β expression and intestinal clearance of Yersinia pseudotuberculosis

AUTHOR(S)
R Dessein
PUB. DATE
June 2009
SOURCE
Gut;Jun2009, Vol. 58 Issue 6, p771
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVE: Yersinia pseudotuberculosis causes ileitis and mesenteric lymphadenitis by mainly invading the Peyer’s patches that are positioned in the terminal ileum. Whereas toll-like-receptor 2 (TLR2) controls mucosal inflammation by detecting certain microbiota-derived signals, its exact role in protecting Peyer’s patches against bacterial invasion has not been defined. DESIGN: Wild-type, Tlr2-, Nod2- and MyD88-deficient animals were challenged by Y pseudotuberculosis via the oral or systemic route. The role of microbiota in conditioning Peyer’s patches against Yersinia through TLR2 was assessed by delivering, ad libitum, exogenous TLR2 agonists in drinking water to germ-free and streptomycin-treated animals. Bacterial eradication from Peyer’s patches was measured by using a colony-forming unit assay. Expression of cryptdins and the c-type lectin Reg3β was quantified by quantitative reverse transcriptase polymerase chain reaction analysis. RESULTS: Our data demonstrated that Tlr2-deficient mice failed to limit Yersinia dissemination from the Peyer’s patches and succumbed to sepsis independently of nucleotide-binding and oligomerisation domain 2 (NOD2). Recognition of both microbiota-derived and myeloid differentiation factor 88 (MyD88)-mediated elicitors was found to be critically involved in gut protection against Yersinia-induced lethality, while TLR2 was dispensable to systemic Yersinia infection. Gene expression analyses revealed that optimal epithelial transcript level of the anti-infective Reg3β requires TLR2 activation. Consistently, Yersinia infection triggered TLR2-dependent Reg3β expression in Peyer’s patches. Importantly, oral treatment with exogenous TLR2 agonists in germ-free animals was able to further enhance Yersinia-induced expression of Reg3β and to restore intestinal resistance to Yersinia. Lastly, genetic ablation of Reg3β resulted in impaired clearance of the bacterial load in Peyer’s patches. CONCLUSIONS: TLR2/REG3β is thus an essential component in conditioning epithelial defence signalling pathways against bacterial invasion.
ACCESSION #
39987809

 

Related Articles

  • Yersinia pseudotuberculosis induces transcytosis of nanoparticles across human intestinal villus epithelium via invasin-dependent macropinocytosis. Ragnarsson, Eva G. E.; Schoultz, Ida; Gullberg, Elisabet; Carlsson, Anders H.; Tafazoli, Farideh; Lerm, Maria; Magnusson, Karl-Eric; Söderholm, Johan D.; Artursson, Per // Laboratory Investigation (00236837);Nov2008, Vol. 88 Issue 11, p1215 

    Crohn's disease is characterized by a defect in intestinal barrier function, where bacteria are considered the most important inflammation-driving factor. Enteric bacteria, including E. coli and Yersinia spp, affect tight junctions in enterocytes, but little is known about bacterial effects on...

  • Yersinia pseudotuberculosis as a cause of ocular disease in goats. Wessels, M. E.; Payne, J.; Willmington, J. A.; Bell, S. J.; Davies, I. H. // Veterinary Record: Journal of the British Veterinary Association;5/29/2010, Vol. 166 Issue 22, p699 

    The article discusses how Yersinia pseudotuberculosis can cause ocular disease in goats. Other conditions associated with the organism include enterocolitis, mesenteric lymphadenitis and septicaemia. Details on the four cases identified by the British Veterinary Laboratories Agency (VLA) that...

  • Immune evasion: Hiding from the inflammasome. David, Rachel // Nature Reviews Microbiology;Jul2010, Vol. 8 Issue 7, p466 

    The article reports on a study that investigates the effect of the type III secretion system (T3SS) during infection by pathogenic yersiniae. It states that the T3SS activate the inflammasome which promote bacterial clearance and inhibited by the effector protein Yopk. It mentions that...

  • Nod2 Mediates Susceptibility to Yersinia pseudotuberculosis in Mice. Meinzer, Ulrich; Esmiol-Welterlin, Sophie; Barreau, Frederick; Berrebi, Dominique; Dussaillant, Monique; Bonacorsi, Stephane; Chareyre, Fabrice; Niwa-Kawakita, Michiko; Alberti, Corinne; Sterkers, Ghislaine; Villard, Claude; Lesuffleur, Thecla; Peuchmaur, Michel; Karin, Michael; Eckmann, Lars; Giovannini, Marco; Ollendorff, Vincent; Wolf-Watz, Hans; Hugot, Jean-Pierre // PLoS ONE;2008, Vol. 3 Issue 7, p1 

    Nucleotide oligomerisation domain 2 (NOD2) is a component of the innate immunity known to be involved in the homeostasis of Peyer patches (PPs) in mice. However, little is known about its role during gut infection in vivo. Yersinia pseudotuberculosis is an enteropathogen causing gastroenteritis,...

  • Mucosal immunology: Battle scars. Bordon, Yvonne // Nature Reviews Immunology;Nov2015, Vol. 15 Issue 11, p668 

    The article focuses on the research findings, which proved that acute gastrointestinal infection in mice can lead to tissue remodelling and the impairment of immune function. Topics discussed under research include infection of mice with Gram-negative bacterium Yersinia pseudotuberculosis, link...

  • "In vitro" activities of antimycobacterial agents against Mycobacterium avium subsp. paratuberculosis linked to Crohn's Disease and Paratuberculosis. Zanetti, Stefania; Molicotti, Paola; Cannas, Sara; Ortu, Silvia; Ahmed, Niyaz; Sechi, Leonardo A. // Annals of Clinical Microbiology & Antimicrobials;2006, Vol. 5, p1 

    The research on activities of antimycobacterial agents against mycobacterium avium linked to paratuberculosis and Crohn's disease. It presents a study of antimycobacterial therapy against M. avium subsp. paratuberculosis (MAP), an infection that may result to Crohn's disease. Strains from 7...

  • Adalimumab/mercaptopurine.  // Reactions Weekly;6/5/2010, Issue 1304, p7 

    The article describes the case of a 50-year-old man who experienced fatal disseminated coccidioidomycosis while receiving adalimumab and mercaptopurine for Crohn's disease. It references a study by S. S. Mitter et al, published in the April 2010 issue of the journal "Nature Reviews...

  • Terminal ileitis due to Yersinia pseudotuberculosis. Savage, A.; Dunlop, D. // British Medical Journal;10/16/1976, Vol. 2 Issue 6041, p916 

    Focuses on the development of acute terminal ileitis in a patient with yersinia pseudotuberculosis. Recognition of yersinia pseudotuberculosis as a cause of mesenteric adenitis; Suggestions for the implementation of serological tests for yersinia during acute illness; Emphasis of the case...

  • Officials offer different versions of gut-bug story, so far. Brown, Ruth // New Zealand Doctor;10/22/2014, p11 

    The article focuses on different versions by government officials regarding the outbreak of Yersinia pseudotuberculosis in Auckland, New Zealand.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics